12.71
price down icon6.54%   -0.8959
 
loading

Dyne Therapeutics Inc Stock (DYN) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.17%
69.16
67.69 62.27 66.74 45.46
Operating Income/Loss
2.17%
-69.16
-67.69 -62.27 -66.74 -45.46
Income/Loss From Continuing Operations Before Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Income/Loss From Continuing Operations After Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Net Income/Loss
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Diluted Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.98
price down icon 2.93%
$23.11
price up icon 1.81%
$34.05
price up icon 1.25%
$20.27
price down icon 2.22%
biotechnology ONC
$245.74
price down icon 9.54%
$113.54
price up icon 0.48%
Cap:     |  Volume (24h):